Coapt Systems Announces Two Key Executive Appointments in Worldwide Marketing, Sales, Research and Development

Friday, September 19, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

PALO ALTO, Calif., Sept. 18 Coapt Systems Inc. announcedtoday the appointments of David Barella as Senior Vice President, GlobalMarketing and Sales, and Bader Bellahsene, PhD, as Vice President, Research,Development and Manufacturing.

"I am very pleased that Dave and Bader have joined our executivemanagement team at Coapt. They each have over twenty years of medical deviceexperience, with a deep, broad level of expertise in the global aestheticmarketplace. Their proven track records, strategic leadership and industryknowledge will be invaluable to us as we continue our growth into newtechnologies, including non-invasive opportunities," commented LaureenDeBuono, President and Chief Executive Officer of Coapt Systems. "Together,we will more deeply penetrate the market with our core products, build thetechnology platform, and expand our business into new markets."

Coapt Systems, founded by a practicing plastic surgeon, develops andmarkets facial rejuvenation products based on novel technology that producesnatural results, reduced recovery time and increased economic value whencompared to traditional facelift procedures. In addition, the Companyreceived FDA clearance this year to market a new injectable vocal fold filler,Novielle Voice(TM), which will be launched September 21, 2008.

"Coapt Systems is seen as a leader in facial aesthetic surgery and I amthrilled to be a part of this executive team," said Barella. "This is anexciting time for Coapt as we demonstrate continued market leadership and workto advance our innovations to offer cost-effective aesthetic procedures in theanti-aging market." Barella added, "Coapt provides value and unmatchedoptions in the aesthetics marketplace. This leading-edge technology helpssurgeons deliver natural looking facial aesthetic results, with a more rapidrecovery, for women and men."

"This Company has a compelling new technology platform and our team iscommitted to the science and innovation required to bring these to market,"says Bellahsene. "It is a natural progression for Coapt to grow beyond itsexpertise in bioabsorbable implants. As such, I am confident we will continueto deliver world class, next generation products to the aesthetic market."

Mr. Barella is a global sales and marketing executive with a thirty yearrecord of outstanding sales growth, market share gain and profitability forFortune-500, as well as privately-held medical device companies. Prior tojoining Coapt, Barella was the Executive Vice President, International Salesand Marketing for MediCor Ltd. Integrating international subsidiaries,Eurosilicone and Nagor, Barella led these combined entities to become the #3market leader in breast, facial and body aesthetic implants outside the UnitedStates. Barella began his aesthetics career as Executive Vice President,Worldwide Sales and Marketing for the McGhan Medical Division of INAMED(acquired by Allergan). He initiated the first successfully commercial,direct-to-consumer marketing programs for breast implants and dermal fillersand was instrumental in leading INAMED to become the worldwide leader infacial and body implants.

Dr. Bellahsene has a proven track record of developing best-in-classproducts with nearly twenty years experience in biomedical device research,design and development. Prior to Coapt Systems, Dr. Bellahsene was VicePresident of Research and Development at Thermage, advancing their technologyand developing a number of products for this leader in non-invasive proceduresto tighten and contour skin. Dr. Bellahsene has also held various technicalleadership positions at companies including Somnus Medical, StrykerCorporation, BCI International, and Polysens. He holds several U.S. andinternational patents, and is the author of numerous scientific publicationsand book chapters.

About Coapt Systems

Coapt Systems Inc. designs,

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store